Safety of onc201 administered two consecutive days per week in pediatric h3 k27m-mutant glioma patients

Authors
Category Primary study
JournalNeuro-Oncology
Year 2021
This article has no abstract
Epistemonikos ID: 5dbc06cc0c56ef55dd3051d2bf9ecaaea2b87b34
First added on: Feb 13, 2025